Novel psychedelic research

Arnold

Bluelighter
Joined
Jan 7, 2008
Messages
12,180
I came across this study and thought that it could be beneficial in general. It is based in the Netherlands where a lot of stuff is legal so hopefully they will keep it that way.
It is also a novel study as in one that not many other do. Plus they will do a trial in the future...

Have you ever taken a novel psychedelic substance?​

Have you ever taken a novel psychedelic substance? Please consider taking part in our new survey!

What’s the survey about? We are about to start a range of experimental trials with novel psychoactive drugs, but we are missing important information- these include things like dose, and experienced positive and negative effects.

So, as the scientific literature is lacking, we want to learn as much as possible from the NPS using community, and are looking for people to tell us more about some of these substances!

If you meet this description, and would be interested in helping out, please follow the link for more information. As always, participation is completely voluntary, and any/all information you give us is entirely anonymous.
We are researchers at the department of Psychopharmacology, in Maastricht University, and would like to invite you to participate in an online study about the use and effects of novel psychedelic substances.

There is increasing interest and use of novel psychedelic substances, including novel phenethylamines (like the 2C series), tryptamines (like the 5-MeO series), and lysergamides (like 1P-LSD and ALD-52).



However, not much information is known about the effects of the substances, and how they are being used. We want to learn more about this and we would therefore like to hear from users about their experiences with any novel psychedelic substance (including those not listed above). Questions are related to your drug use history and experiences. At the end of the questionnaire, you will have room to add additional comments.



Important information for you:



You will be asked demographic information about yourself (age, sex, gender, country of birth, and highest level of education). You will then be asked about your experience with novel psychedelic substances, including which substances you have taken, how you took them (dose and route of administration), and how you felt during the drug experience.



Participation in the study is completely voluntary. You have the right to decline to participate, and you can stop the survey and withdraw from the study at any time, without any negative consequences, and without providing a reason.



For this study no personal data about you will be used and stored by Maastricht University. The study is completely anonymous so the study data cannot be traced back to you in any way.The fully anonymous research data that apply to me will be re-used in future or other research.


Completing this survey takes about 15 minutes, depending on your speed. You can at any time stop the survey. If you decide to stop, you can also go back to the survey at any time.



There are no direct benefits or risks in participating in this research.



This research is ethically reviewed and approved by the Ethical Committee of Psychology and Neuroscience (ERCPN), Maastricht University, reference ERCPN_222_77_04_2020. In case you decide to fill out the questionnaire, we ask that you take the questions seriously so that science can benefit from your experience with psychedelics. Of note, Maastricht University does not in any way encourage the use of any of the aforementioned substances, and excludes any responsibility for their use.



After reading the aforementioned information, the researchers invite you to reflect on if you would like to participate. In case you have additional questions after reading this information you can always contact one of the researchers by mail:
https://maastrichtuniversity.eu.qualtrics.com/jfe/form/SV_cRXWwjnuHXa7Ty5
 
Last edited:
Top